SUPRIYA LIFESCIENCE
|
The Current P/E Ratio of SUPRIYA LIFESCIENCE is 29.19.
Share Price | ₹681.5 | Jun 20,2025 |
Market Cap | ₹5,486.1 Cr | |
Earnings-TTM | ₹188.0 Cr | TTM-Standalone Results |
Price/Earnings | 29.19x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of SUPRIYA LIFESCIENCE
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹5,486.1 Cr] as on Jun 20,2025
(/) Earnings [ ₹188.0 Cr] based on TTM-Standalone Results
(=) P/E Ratio [ 29.19x ]
Thus, for SUPRIYA LIFESCIENCE , the investors are currently willing to pay 29.19 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of SUPRIYA LIFESCIENCE !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of SUPRIYA LIFESCIENCE over the last five years.
Historical PE (Price/Earnings) ratio chart of SUPRIYA LIFESCIENCE
PE Ratio Performance Analysis for SUPRIYA LIFESCIENCE
- SUPRIYA LIFESCIENCE 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 13.13x.
- SUPRIYA LIFESCIENCE 's operated at median p/e ratio of 17.08x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, SUPRIYA LIFESCIENCE 's p/e ratio peaked in Mar2022 at 26.13x.
- SUPRIYA LIFESCIENCE 's p/e ratio hit its five-year low in Mar2021 of 0x.
How does SUPRIYA LIFESCIENCE 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
SUPRIYA LIFESCIENCE | 187.96 | 29.19 | 5,486.1 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 10,980.10 | 36.36 | 399,249.0 |
DIVIS LABORATORIES LTD | 2,191.00 | 79.84 | 174,940.0 |
CIPLA LTD | 5,291.05 | 22.91 | 121,197.0 |
TORRENT PHARMACEUTICALS LTD | 1,911.00 | 56.12 | 107,250.0 |
DR REDDYS LABORATORIES LTD | 5,703.50 | 19.39 | 110,618.0 |
MANKIND PHARMA LTD | 2,003.22 | 47.16 | 94,475.7 |
ZYDUS LIFESCIENCES LTD | 4,614.80 | 20.87 | 96,296.6 |
LUPIN LTD | 3,306.26 | 26.89 | 88,907.2 |
AUROBINDO PHARMA LTD | 3,515.26 | 18.11 | 63,667.5 |
ABBOTT INDIA LTD | 1,414.44 | 47.37 | 66,997.1 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs SUPRIYA LIFESCIENCE 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 18.11x |
Max industry PE | 79.84x |
Median industry PE | 29.19x |
Average industry PE | 36.75x |
You may also like the below Video Courses